CCN3 Is a Therapeutic Target Relating Enhanced Stemness and Coagulation in Hepatocellular Carcinoma

Scientific Reports - United Kingdom
doi 10.1038/s41598-017-14087-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

PI3Kδ Is a New Therapeutic Target in Hepatocellular Carcinoma

Hepatology
MedicineHepatology
2018English

Aminoacylase 3 Is a New Potential Marker and Therapeutic Target in Hepatocellular Carcinoma

Journal of Cancer
Oncology
2018English

MicroRNAs in Hepatocellular Carcinoma: Carcinogenesis, Progression, and Therapeutic Target

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2014English

C-Met: A Potential Therapeutic Target for Hepatocellular Carcinoma

Drug discoveries & therapeutics
MedicineToxicologyPharmaceuticsPharmacology
2011English

Survivin Is a Therapeutic Target in Merkel Cell Carcinoma

Science Translational Medicine
Medicine
2012English

BRAF Is a Therapeutic Target in Aggressive Thyroid Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2006English

TLR 4 Increases the Stemness and Is Highly Expressed in Relapsed Human Hepatocellular Carcinoma

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Somatostatin in Hepatocellular Carcinoma: Experimental and Therapeutic Implications

Hepatoma Research
2018English

Hepatic Stellate Cells Transmigration and Remodeling Are Related to CCN3 in Oxaliplatin-Resistant Hepatocellular Carcinoma

Oncotarget
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy